Oré AJF; La Torre CLM; Urteaga QRJ

Language: Spanish
References: 14
Page: 165-171
PDF size: 256.92 Kb.

ABSTRACT

Introduction: Cystic lymphomas are malformations of the lymphatic ducts, which form cavities with lymphatic fluid. Objective: To determine the clinical characteristics, evolution and prognosis of patients undergoing surgery due to lymphatic malformations located in the head and neck. Design: Case series Methods: The medical records of patients who underwent a lymphatic malformation resection at The Head, Neck and Maxillofacial Surgery Unit, who had a pathological analysis compatible with lymphatic malformations, during the period from January 2008 to January 2017. Results: We found 254 cases that required surgery, with a median age of 1 year and an average of 2.9 years. The cervical region had the highest presentation (77.6%) specifically in the unilateral supra and infrahyoid location (30.3%). The appearance of a tumor was the most frequent sign (98.8%). 5.9% of recurrences were found for surgical treatment and 8.2% of cases with paresis or paralysis of the submandibular nerve as sequelae. 10 cases required tracheostomy and 3 patients died due to complications after surgery. Conclusions: Surgical treatment is indicated for cystic lymphangiomas. It minimizes morbidity and prevents recurrences.

REFERENCES

1. Valle-Rodríguez E, Villanueva-San Vicente V, Rodríguez-González MA, Segarra-Fenoll D, García-Mateos MJ,Méndez-Trujillo S. Linfangioma cervical: manejo terapéuticocon OK-432 (Picibanil). Rev Esp Cir Oral y Maxilofac. 2007;29(6),399-403.

2. Zavala A, Maira A, Montes P, Zuñiga S, Navarrete A, Ogita S.Linfangiomas cérvico faciales pediátricos tratamiento con OK-432. Rev Otorrinolaringol Cir Cab-Cuello. 2001;61,37-42.

3. Okazaki T, Iwatani S, Yanai T, Kobayashi H, Kato Y, MarusasaT, et al. Treatment of lymphangioma in children: our experienceof 128 cases. J Pediatr Surg. 2007;42(2):386–389.

4. Bai Y, Jia J, Huang XX, Alsharif MJ, Zhao JH, Zhao YF.Sclerotherapy of microcystic lymphatic malformations in Oraland Facial Regions. J Oral Maxillo Surg. 2007;67(2):251-256.

5. Shiels WE 2nd, Kang DR, Murakami JW, Hogan MJ, WietGJ. Percutaneous treatment of lymphatic malformations.Otolaryngol Head Neck Surg. 2009;141(2):219-224.

6. Perkins JA, Manning S, Tempero RM, Cunningham MJ,Edmonds JL Jr, Hoffer FA, et al. Lymphatic malformations:Review of current treatment. Otolaryngol Head Neck Surg.2010;142(6):795-803.

7. Colbert SD, Seager L, Haider F, Evans BT, Anand R,Brennan PA. Lymphatic malformations of the head and neckcurrentconcepts in management. Br J Oral Maxillofac Surg.2013;51,98-102.

8. de Serres LM, Sie KC, Richardson MA. Lymphaticmalformations of the head and neck. A proposal for staging.Arch Otolaryngol Head Neck Surg. 1995;121:577–582.

9. Perkins JA, Manning SC, Tempero RM, Cunningham MJ,Edmonds JL Jr, Hoffer FA, et al. Lymphatic malformations:Current cellular and clinical investigations. Otolaryngol HeadNeck Surg. 2010;142:789-794.

10. Gimeno-Aranguez M, Colomar-Palmer P, González-MedieroI, Ollero-Caprani JM. Aspectos clínicos y morfológicos de loslinfangiomas infantiles: Revisión de 145 casos. An Esp Pediatr.1996;45:25-28.

11. Hartl DM, Roger G, Denoyelle F, Nicollas R, Triglia JM,Garabedian EN. Extensive lymphangioma presenting withupper airway obstruction. Arch Otolaryngol Head Neck Surg.2000;126:1378-1382.

12. Nehra D, Jacobson L, Barnes P, Mallory B, Albanese CT,Sylvester KG. Doxycycline sclerotherapy as primary treatmentof head and neck lymphatic malformations in children. J PediatrSurg. 2008;43:451–460.

13. Fujino A, Moriya Y, Morikawa Y, Hoshino K, WatanabeT, Shimomija N, et al. A Role of Cytokines in OK-432injection therapy for cystic lymphangioma: an approach to themechanism. J Pediatr Surg. 2003;38(12):1806-9.

14. Alqahtani A, Nguyen LT, Flageole H, Shaw K, Laberge JM.25 years’ experience with lymphangiomas in children. J PediatrSurg.1999;34(7):1164-8.